<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	 xmlns:media="http://search.yahoo.com/mrss/" >

<channel>
	<title>2018/11/15 &#8211; CRI Report</title>
	<atom:link href="https://www.cri-report.com/publication-date/2018-11-15/feed/" rel="self" type="application/rss+xml" />
	<link>https://www.cri-report.com</link>
	<description>market research vender!</description>
	<lastBuildDate>Wed, 24 Nov 2021 00:27:11 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	

<image>
	<url>https://www.cri-report.com/wp-content/uploads/2021/01/cropped-shcrilogo-c.jpg</url>
	<title>2018/11/15 &#8211; CRI Report</title>
	<link>https://www.cri-report.com</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>Global Active Pharmaceutical Ingredients Market Research Report &#8211; Forecast to 2023</title>
		<link>https://www.cri-report.com/global-active-pharmaceutical-ingredients-market-research-report-forecast-to-2023/</link>
		
		<dc:creator><![CDATA[admin]]></dc:creator>
		<pubDate>Fri, 07 Dec 2018 02:40:51 +0000</pubDate>
				<guid isPermaLink="false">https://www.cri-report.com/product/import-placeholder-for-180441/</guid>

					<description><![CDATA[<p>The global active pharmaceutical ingredient market is expected to reach to a market value of USD 215,125.4 million by 2023 from USD 161,143.2 million in 2017 and is expected to register a CAGR of 4.93% during the forecast period from 2018 to 2023.</p>
<p>The post <a rel="nofollow" href="https://www.cri-report.com/global-active-pharmaceutical-ingredients-market-research-report-forecast-to-2023/">Global Active Pharmaceutical Ingredients Market Research Report &#8211; Forecast to 2023</a> first appeared on <a rel="nofollow" href="https://www.cri-report.com">CRI Report</a>.</p>
]]></description>
										<content:encoded><![CDATA[<p>Introduction<br />
Active <a href="https://www.cri-report.com/southeast-asia-pharmaceutical-industry/" data-internallinksmanager029f6b8e52c="2405" title="Research Report on Southeast Asia Pharmaceutical Industry 2023-2032" target="_blank" rel="noopener">pharmaceutical</a> ingredient (API) is a biologically active <a href="https://www.cri-report.com/southeast-asia-pharmaceutical-industry/" data-internallinksmanager029f6b8e52c="2405" title="Research Report on Southeast Asia Pharmaceutical Industry 2023-2032" target="_blank" rel="noopener">pharmaceutical</a> drug. API can be obtained by a synthetic process or from natural sources. The increasing occurrence of chronic diseases, rising acceptance, and uptake of pharmaceuticals, growth in abbreviated new drug applications (ANDA), and the growing importance of generics are expected to drive market growth. For instance, according to the report published by the Centers for Disease Control and Prevention (CDC), nearly 92.1 million adults in the US dealt with at least one type of cardiovascular diseases in 2017. However, stringent regulatory policies and adverse drug p<a href="https://www.cri-report.com/vietnams-rice-industry-2016-2030/" data-internallinksmanager029f6b8e52c="1966" title="Research Report on Vietnam&#039;s Rice Industry 2016-2030" target="_blank" rel="noopener">rice</a> control policies across numerous countries may hamper the growth of the market.<br />
The global active <a href="https://www.cri-report.com/southeast-asia-pharmaceutical-industry/" data-internallinksmanager029f6b8e52c="2405" title="Research Report on Southeast Asia Pharmaceutical Industry 2023-2032" target="_blank" rel="noopener">pharmaceutical</a> ingredient market is expected to reach to a market value of USD 215,125.4 million by 2023 from USD 161,143.2 million in 2017 and is expected to register a CAGR of 4.93% during the forecast period from 2018 to 2023. In 2016, the market was led by the Americas with a 40.7% share, followed by Europe and Asia-Pacific with shares of 27.0% and 24.8%, respectively. The increasing burden of chronic diseases has been observed in different parts of the world which has upsurge the growth of the market.<br />
The global active <a href="https://www.cri-report.com/southeast-asia-pharmaceutical-industry/" data-internallinksmanager029f6b8e52c="2405" title="Research Report on Southeast Asia Pharmaceutical Industry 2023-2032" target="_blank" rel="noopener">pharmaceutical</a> ingredients market is segmented by manufacturing process, by type of synthesis, by API formulation, by application, by molecule, and by region.<br />
The global active pharmaceutical ingredients market, by manufacturing process, is segmented into captive manufacturing and contract manufacturing.<br />
The global active pharmaceutical ingredients market, by type of synthesis, is segmented into synthetic and biotech.<br />
The global active pharmaceutical ingredients market, by API formulation, is segmented into generic API and innovative API.<br />
By application, the global active pharmaceutical ingredients market is segmented into cardiovascular disease, <a href="https://www.cri-report.com/global-flow-cytometry-in-oncology-market-focus-on-product-type-technology-type-of-cancer-applications-end-users-country-data-16-countries-and-competitive-landscape-analysis-and-forecast-20/" data-internallinksmanager029f6b8e52c="916" title="Global Flow Cytometry in Oncology Market: Focus on Product Type, Technology, Type of Cancer, Applications, End Users, Country Data (16 Countries), and Competitive Landscape - Analysis and Forecast, 2021-2031" rel="nofollow noopener" target="_blank">oncology</a>, neurological disorders, orthopedic disorders, respiratory, <a href="https://www.cri-report.com/oil-and-gas-industry-in-india-2021/" data-internallinksmanager029f6b8e52c="1678" title="Oil and Gas Industry in India 2021" target="_blank" rel="noopener">gas</a>trointestinal disorders, urology, and others.<br />
By molecule, the global active pharmaceutical ingredients market is segmented into small molecule and large molecule.<br />
The global active pharmaceutical ingredient market is expected to reach to a market value of USD 215,125.4 million by 2023 from USD 161,143.2 million in 2017 and is expected to register a CAGR of 4.93% during the forecast period from 2018 to 2023.<br />
Key Players<br />
Sanofi, Bayer AG, Pfizer Inc., F. Hoffmann-La Roche AG, Abbott Laboratories, Merck &amp; Co., Inc, Bo<a href="https://www.cri-report.com/electronic-health-records-ehr-market/" data-internallinksmanager029f6b8e52c="1785" title="Global Electronic Health Records (EHR) Market Outlook 2030: Industry Insights &amp; Opportunity Evaluation, 2019-2030" target="_blank" rel="noopener">ehr</a>inger Ingelheim GmbH, GlaxoSmithKline Plc (GSK), Novartis AG, Eli Lilly and Company, and Teva Pharmaceutical Industries Ltd, and others.<br />
Study objectives<br />
• To provide a detailed analysis of the market structure along with the forecast of various segments and sub-segments of the active pharmaceutical ingredients market<br />
• To provide insights into factors affecting the market growth<br />
• To analyze the global active pharmaceutical ingredients market based on various tools such as supply chain analysis and Porter’s five force analysis<br />
• To provide historical and forecast revenue of market segments and sub-segments with respect to regions and their respective key countries<br />
• To provide country-level analysis of the market with respect to current market size and future perspective<br />
• To provide country-level analysis of the market for segments by manufacturing process, by type of synthesis, by API formulation, by application, by molecule, and by region<br />
• To provide strategic profiling of key players in the market, comprehensively analyzing their core competencies, and drawing a competitive landscape for the market<br />
• To track and analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments in the active pharmaceutical ingredients market<br />
Target Audience<br />
• Pharmaceutical and Biotechnology Companies<br />
• Research and Development (R&amp;D) Companies<br />
• Government Research Institutes<br />
• Academic Institutes and Universities<br />
Key Findings<br />
• The global active pharmaceutical ingredients market is expected to reach USD 215,125.4 million by 2023 from USD 161,143.2 million in 2017 and is expected to register a CAGR of 4.93% during the forecast period from 2018 to 2023.<br />
• On the basis of manufacturing process, the captive manufacturing segment is expected to account for the largest market share at a CAGR of 4.78% by 2023<br />
• Based on type of synthesis, the synthetic segment is expected to account for the largest market share at a CAGR of 4.89% by 2023<br />
• Based on API formulation, the generic API segment is expected to account for the largest market share at a CAGR of 4.62% by 2023<br />
• Based on application, the cardiovascular disease segment is expected to account for the largest market share at a CAGR of 3.74% by 2023<br />
• Based on molecule, the small molecule segment is expected to account for the largest market share at a CAGR of 4.89% by 2023<br />
• The Americas is expected to hold the largest share of the global active pharmaceutical ingredients market at a CAGR of 4.74% by 2023<br />
• Asia-Pacific is the fastest growing market, which is expected to register a CAGR of 5.27% by 2023<br />
Regional Analysis<br />
• Americas<br />
o North America<br />
 US<br />
 Canada<br />
o South America<br />
• Europe<br />
o Germany<br />
o France<br />
o UK<br />
o Italy<br />
o Spain<br />
o Rest of Europe<br />
• Asia-Pacific<br />
o Japan<br />
o China<br />
o India<br />
o Australia<br />
o Republic of Korea<br />
o Rest of Asia-Pacific<br />
• Middle East &amp; Africa<br />
o Middle East<br />
o Africa</p>
<p>The post <a rel="nofollow" href="https://www.cri-report.com/global-active-pharmaceutical-ingredients-market-research-report-forecast-to-2023/">Global Active Pharmaceutical Ingredients Market Research Report &#8211; Forecast to 2023</a> first appeared on <a rel="nofollow" href="https://www.cri-report.com">CRI Report</a>.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Analytical Report on Soybean Import in China, 2018-2022</title>
		<link>https://www.cri-report.com/analytical-report-on-soybean-import-in-china/</link>
		
		<dc:creator><![CDATA[admin]]></dc:creator>
		<pubDate>Thu, 15 Nov 2018 02:04:08 +0000</pubDate>
				<guid isPermaLink="false">https://www.cri-report.com/product/import-placeholder-for-1811350/</guid>

					<description><![CDATA[<p>In 2017, the soybean import from Brazil and the U.S. reached 50.93 million tons and 32.85 million tons respectively, accounting for 53.3% and 34.4% respectively of the total soybean imports.</p>
<p>The post <a rel="nofollow" href="https://www.cri-report.com/analytical-report-on-soybean-import-in-china/">Analytical Report on Soybean Import in China, 2018-2022</a> first appeared on <a rel="nofollow" href="https://www.cri-report.com">CRI Report</a>.</p>
]]></description>
										<content:encoded><![CDATA[<p>&nbsp;</p>
<h5><span style="color: #ff6600;">Updated Report: <a style="color: #ff6600;" href="https://www.cri-report.com/research-report-on-imported-soybeans-in-china-2020-2024/">Research report on imported soybeans in China 2020-2024</a></span></h5>
<h3>Soybean Import Overview</h3>
<p>As the largest soybean consumer in the world, China consumed about 110 million tons of soybeans in 2017, about one-third of the world&#8217;s total soybean consumption. In China, soybeans are mainly used for the extraction of edible <a href="https://www.cri-report.com/oil-and-gas-industry-in-india-2021/" data-internallinksmanager029f6b8e52c="1678" title="Oil and Gas Industry in India 2021" target="_blank" rel="noopener">oil</a>s and the making of bean products. Soybean meal, the by-product of <a href="https://www.cri-report.com/oil-and-gas-industry-in-india-2021/" data-internallinksmanager029f6b8e52c="1678" title="Oil and Gas Industry in India 2021" target="_blank" rel="noopener">oil</a> extraction, is a high-quality <a href="https://www.cri-report.com/southeast-asia-feed-industry/" data-internallinksmanager029f6b8e52c="2359" title="Research Report on Southeast Asia Feed Industry 2023-2032" target="_blank" rel="noopener">feed</a> that is widely used in China&#8217;s livestock breeding industry.</p>
<p>China&#8217;s soybean consumption is rising. However, soybean planting is a low-profit and even money-losing industry in China in the context of low-level agricultural technologies and rising labor costs, which makes it difficult to significantly increase domestic soybean yields.</p>
<p>For example, from 2012 to 2017, China&#8217;s soybean consumption surged from 74.85 million tons to 112.18 million tons while its soybean yields just increased from 13.01 million tons to 14.55 million tons. In 2015, the soybean yields even fell to 11.78 million tons.</p>
<p>The wide gap between the yields and consumption forces Chinese companies to satisfy the market demand by importing soybeans. From 2013 to 2017, the import volume of soybeans in China inched up from 58.38 million tons to 95.53 million tons.</p>
<p>In 2017, the soybeans imported from Brazil and the U.S. reached 50.93 million tons and 32.85 million tons respectively, accounting for 53.3% and 34.4% respectively of the total soybean imports.</p>
<p>The more important reason for China’s largely importing soybeans is that foreign soybeans have higher yields and <a href="https://www.cri-report.com/oil-and-gas-industry-in-india-2021/" data-internallinksmanager029f6b8e52c="1678" title="Oil and Gas Industry in India 2021" target="_blank" rel="noopener">oil</a> yields. Thanks to transgenic species, large-scale planting and modernized agricultural technologies, the major soybean producing countries in South and North America outperform China in both planting cost control and per unit area yield, and thus have distinct p<a href="https://www.cri-report.com/vietnams-rice-industry-2016-2030/" data-internallinksmanager029f6b8e52c="1966" title="Research Report on Vietnam&#039;s Rice Industry 2016-2030" target="_blank" rel="noopener">rice</a> advantages.</p>
<p>This is also the core reason why imported soybeans occupy a major share of the Chinese market. In addition, higher <a href="https://www.cri-report.com/oil-and-gas-industry-in-india-2021/" data-internallinksmanager029f6b8e52c="1678" title="Oil and Gas Industry in India 2021" target="_blank" rel="noopener">oil</a> yields of imported soybeans are also an advantage over domestic ones. The oil yields of domestic soybeans range from 16% to 17%, while those of imported transgenic ones range from 19% to 20%, which are 3% higher.</p>
<p>This difference directly affects the profits on soybean crushing. On the whole, domestic soybeans cannot compete with imported ones either in p<a href="https://www.cri-report.com/vietnams-rice-industry-2016-2030/" data-internallinksmanager029f6b8e52c="1966" title="Research Report on Vietnam&#039;s Rice Industry 2016-2030" target="_blank" rel="noopener">rice</a>s or in oil yields.</p>
<p>China&#8217;s soybean industry is heavily reliant on imports and is thus vulnerable to the impact of international soybean p<a href="https://www.cri-report.com/vietnams-rice-industry-2016-2030/" data-internallinksmanager029f6b8e52c="1966" title="Research Report on Vietnam&#039;s Rice Industry 2016-2030" target="_blank" rel="noopener">rice</a>s. China has weak pricing power on the soybean market. To encourage soybean planting, the Chinese government has introduced some incentives, for example, government subsidies. However, the incentives including low subsidies are not effective enough to dramatically increase domestic soybean yields.</p>
<p>In Jul. 2018, the <a href="https://www.gov.cn/" target="_blank" rel="noopener">Chinese government</a> began to impose a 25% retaliatory tariff on U.S. goods including soybeans, which made the cost of importing U.S. soybeans about 40 USD/ton to 50 USD/ton higher than that of importing Brazilian soybeans. In this context, some Chinese importers are considering turning to Brazil.</p>
<p>Although Brazil is the world&#8217;s largest soybean exporter, Brazilian soybeans are unlikely to completely replace the soybean imports from the U.S. It is mainly because that the soybean imports from other countries like Argentina, Paraguay and Canada total less than 15 million tons every year, and have limited growth potential.</p>
<p>It is expected that with an expanding population and improving living standards, the demand for soybeans in China will continue to grow in the next few years. As the domestic soybean yields can hardly be increased, over 80% soybean consumption will rely on imports.</p>
<p>There are many uncertainties in the Sino-U.S. trade war. If China and the U.S. can reach a compromise on bilateral trade, in 2019, U.S. soybean imports to China may rebound rapidly; otherwise, the tariffs will remain at the current level or be increased, and there will be a surge in the p<a href="https://www.cri-report.com/vietnams-rice-industry-2016-2030/" data-internallinksmanager029f6b8e52c="1966" title="Research Report on Vietnam&#039;s Rice Industry 2016-2030" target="_blank" rel="noopener">rice</a>s and a plummet in the volume of U.S. soybeans imported to China.</p>
<p>Even if Chinese importers turn their attention to countries such as Brazil, the soaring demand will push up the prices of soybeans from these countries and press Chinese importers in cost. Overall, the ongoing Sino-U.S. trade war will increase the cost of importing soybeans, which means that Chinese consumers will have to pay more for soybean oil, bean products, <a href="https://www.cri-report.com/southeast-asia-dairy-products-industry/" data-internallinksmanager029f6b8e52c="2457" title="Research Report on Southeast Asia Dairy Products Industry 2023-2032" target="_blank" rel="noopener">dairy products</a>, pork, eggs, etc.</p>
<p>Topics Covered:<br />
&#8211; Demand for soybeans in China<br />
&#8211; Status of soybean planting in China<br />
&#8211; Soybean import in China<br />
&#8211; Major Chinese importers of soybeans<br />
&#8211; Major sources of soybean imports to China<br />
&#8211; Impact of Sino-U.S. trade war on China&#8217;s import of soybeans<br />
&#8211; Forecasts on soybean import in China from 2019 to 2023</p>
<p>The post <a rel="nofollow" href="https://www.cri-report.com/analytical-report-on-soybean-import-in-china/">Analytical Report on Soybean Import in China, 2018-2022</a> first appeared on <a rel="nofollow" href="https://www.cri-report.com">CRI Report</a>.</p>
]]></content:encoded>
					
		
		
			</item>
	</channel>
</rss>
